Меню
Идёт набор NCT04288635

Impact of Metabolite Supplementation to Restore Mitochondrial Dysfunction During Septic Shock: a Preclinical Study

Наблюдательное Septic Shock Multiple Organ Failure

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Whole blood samples.
Кому может быть актуально
Состояния в реестре: Septic Shock, Multiple Organ Failure. Базовые параметры: от 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Франция
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Impact of Metabolite Supplementation to Restore Mitochondrial Dysfunction During Septic Shock: a Preclinical Study: MEFDASE Study

Обзор

Septic shock is defined as a subset of sepsis with severe metabolism alterations, leading to organ failure. Septic shock is associated with a high mortality, around 40% according to the SEPSIS 3 definition. Metabolic alterations are responsible for lactic acidosis, and results in mitochondrial dysfunction. This study aims at evaluate the impact of exogenous metabolites on restoring mitochondrial function in septic shock patients with lactate acidosis. Mitochondrial metabolism (quantitative analysis, mitochondrial function) in intact Peripheral Blood Mononuclear Cells (PBMC) will be isolate and analyse from patients at the early phase of septic shock (admission), at day 2 and 4. Participant's medical history will be recorded: renal and liver metabolism, severity scores and outcomes and the need for supportive care in the intensive care unit (ICU) until 28 days after admission. Furthermore, the investigators will evaluate wether selected metabolites added to the cell culture medium may improve mitochondrial metabolism.

Подробное описание

In this prospective study, the investigators will include patients admitted to the medical ICU of Angers University Hospital and meeting the SEPSIS-3 criteria for the definition of septic shock (Sequential Organ Failure Assessment (SOFA) score \> 2, hyperlactatemia \> 2 mmol/L and sepsis).

Blood samples will be collected during the usual care of initial resuscitation and analyzed in the laboratory INSERM (Institut national de la santé et de la recherche médicale) U1232 (University Hospital of Angers).

Mitochondrial metabolism will be analyzed in freshly isolated PBMC and after culture for 1-3 days, with or without the addition of selected metabolites to the cell culture medium.

The evolution of ketogenesis, mitochondrial function, acidobasic status will be assessed across the time (blood samples at day 2 and 4).

Survival, renal and liver metabolism, severity scores and outcomes and the need for supportive care in the intensive care unit (ICU) until 28 days after admission will be recorded.

Вмешательства

  • Биопрепарат Whole blood samples
    Whole blood samples at admission, from day one to three after admission

Первичные конечные точки

  • Change in mitochondrial metabolism (mitochondrial membrane depolarization and respiration) with the supplementation of metabolite in the cell culture medium [Срок оценки: Day 0 (whole blood after cells separation), Day 1-3 after cell culture]
Вторичные конечные точки (6)
  • Overall survival at 28 days [Срок оценки: Day 28]
  • Change in organs failure [Срок оценки: From Day 0 to Day 4]
  • Change and correlation between lactic acidosis, ketogenesis and mitochondrial function evolutions [Срок оценки: From Day 1 to Day 3]
  • Need for renal replacement therapy during the ICU stay [Срок оценки: From Day 1 to Day 28]
  • Need for vasopressors during the ICU stay [Срок оценки: From Day 1 to Day 28]
  • Need for mechanical ventilation during the ICU stay [Срок оценки: From Day 1 to Day 28]

Критерии участия

Критерии включения

  • All patients aged 18 or more
  • Patients with criteria for septic shock according to SEPSIS 3 definition (presumed sepsis, with persisting hypotension requiring vasopressors to maintain mean arterial pressure > 65 mmHg and having a serum lactate > 2 mmol/L despite adequate fluid expansion).
  • Admitted in the ICU of Angers University Hospital

Критерии исключения

  • Minor patients (aged less 18)
  • Patient subject to legal protection measures
  • Refusal of the patient or his family
  • Preexisting mitochondrial disease
  • Patient with aplasia
  • Pregnant or parturient women

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Модель наблюдения
Когортное

Центры проведения

Франция · 1 центр
  • CHU — Angers

Идентификаторы

NCT: NCT04288635 · 49RC19_0189

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗